Author

A. Kneppers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

R. Mounier· 3 shared S. Ben Larbi· 2 shared A. Fessard· 1 shared A. Saugues· 1 shared A. Thomas· 1 shared B. Blachot-Minassian· 1 shared B. Chazaud· 1 shared B. Stella· 1 shared

Activity by Year

2024-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPathology

R. Mounier

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Polymeric nanoparticles delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne Muscular Dystrophy

I. Andreana, A. Kneppers, S. Ben Larbi, F. Tifni, A. Fessard, J. Sidi-Boumedine, D. Kryza, B. Stella, C. Bordes, S. Arpicco, Y. Chevalier, B. Chazaud, R. Mounier, G. Lollo, G. Juban

This paper shows that delivering AMPK activator 991 via polymeric nanoparticles reduces toxicity and improves muscle homeostasis in a DMD mouse model.

bioRxiv · Jan 16, 2024Pathology

Impaired skeletal muscle regeneration induced by Cre recombinase activation in skeletal muscle stem cells

A. Kneppers, A. Saugues, C. Dabadie, S. Ben Larbi, R. Mounier

This study shows that Cre recombinase activation in skeletal muscle stem cells impairs muscle regeneration, highlighting off-target effects of Pax7CreERT2 mice.

bioRxiv · Jan 15, 2024 · PreprintCell Biology

Metformin protects the heart against chronic intermittent hypoxia through AMPK-dependent phosphorylation of HIF-1α

S. Moulin, B. Blachot-Minassian, A. Kneppers, A. Thomas, S. Paradis, L. Bultot, C. Arnaud, J.-L. Pepin, L. Bertrand, R. Mounier, E. Belaidi

This study shows metformin protects the heart from chronic intermittent hypoxia by activating AMPK2, which phosphorylates and inhibits HIF-1α, reducing mitochondrial damage.

bioRxiv · Jan 11, 2024Physiology